glp 1 comorbidities Breakthrough of the Year: GLP-1 Agonists and Cardiometabolic Disease Manufacturers Must Adapt to Growing
Description
10.1002/phar.1507
Weight loss is not appropriate during these periods, and the effects of GLP-1 activation on fetal development or infant nutrition are unknown
If you are considering GLP-1 treatments, choose those that are safe, approved, and effective
A comprehensive literature search was conducted to identify studies evaluating the association between GLP1RAs and psychiatric outcomes
The decision should always be individualized
26(9): p
